• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Medtronic, IBM Watson Health launch AI-powered diabetes management app

June 27, 2018 By Sarah Faulkner

Medtronic, IBM Watson's Sugar.IQ AI-powered diabetes appMedtronic (NYSE:MDT), in partnership with IBM Watson Health, this week announced commercial availability of its AI-powered Sugar.IQ diabetes management app.

Using artificial intelligence, the Sugar.IQ app evaluates how a user’s blood sugar levels respond to variables such as food intake, insulin dosing and other daily routines.

At this year’s meeting of the American Diabetes Association, Medtronic reported that people who used the Sugar.IQ system spent 36 minutes more per day in a healthy glucose range than they did before using the app – including 30 minutes less in hyperglycemia and 6 minutes less in hypoglycemia.

The app is available with Medtronic’s Guardian Connect continuous glucose monitoring system, which is designed to give users predictive alerts up to 60 minutes before they experience hyper- or hypoglycemia.

“Sugar.IQ has given me insights that I could never have uncovered on my own – even with 30 years of diabetes experience. It’s been eye opening and fun to gain new insights into my diabetes without additional burden,” said Michelle Shaw, a Medtronic employee and registered nurse.

“Data-driven technologies like AI, machine learning and analytics are changing the way people manage their health today, and the launch of the Sugar.IQ app with Watson is an indication of where the future of disease management is headed,” Dr. Kyu Rhee, VP & chief health officer at IBM Watson Health, said in prepared remarks.”Through IBM Watson Health’s partnership with Medtronic, we’re bringing the power of AI to the everyday lives of people with diabetes, with the goal of lessening the burden of disease.”

Want to stay on top of DDBN content? Sign up for our e-mail newsletter for a weekly dose of drug-device news.

Filed Under: Diabetes, Featured, mHealth (Mobile Health), Patient Monitoring, Wall Street Beat Tagged With: IBM Watson Health, Medtronic

IN CASE YOU MISSED IT

  • Glucotrack to effect a reverse stock split
  • Medtronic unveils ‘MiniMed’ as name for soon-to-be separated Diabetes unit
  • Insulet, Marvel collab to unveil comic book hero with type 1 diabetes
  • Insulet rolls out new Omnipod 5 iPhone app for use with Dexcom G7
  • Tandem, Abbott strike deal to pair insulin pumps with glucose-ketone monitor

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS